Naslov
COMPARISON OF OUTPATIENT UTILIZATION OF PSYCHOPHARMACEUTICALS BETWEEN ZAGREB AND SCANDINAVIAN COUNTRIES (2001-2006)

Autori
D. Štimac, J. Čulig, Z. Šostar, M. Bucalić

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Periodicum bilogorum vol 109, suppl 2 / - Zagreb, 2007, 83-83

ISBN
0031-5362

Skup
5th croatian congress of pharmacology and 2nd congress of croatian physiological society

Mjesto i datum
Osijek, Hrvatska, 19.09.2007. - 22.09.2007

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
psychopharmaceuticals; Croatia; Scandinavian countries; ATC/DDD methodology

Sažetak
Introduction: Neurotropic drugs account for 15% of total drug utilization in the City of Zagreb. The aim was to estimate outpatient consumption of psychotropic drugs in Zagreb in correlation with Scandinavian countries. Methods: Data on drug utilization in Zagreb were collected and analyzed for the 2001-2006 period. Data were obtained from Zagreb Municipal Pharmacy and extrapolated to the total number of pharmacies. All drugs were classified according to Anatomical-Therapeutic-Chemical (ATC) drug classification system. These data were used to calculate the number of defined daily doses (DDD) and DDD per 1000 inhabitants per day (DDD/TID). Data of the Nordic Medico-Statistical Committee were used for Scandinavian countries. Results: In Zagreb, total utilization of psychopharmaceuticals of 115.4 DDD/TID in 2001, 104.5 DDD/TID in 2002, 106.9 DDD/TID in 2003, 101.2 DDD/TID in 2004, 95.5 DDD/TID in 2005 and 93.15 DDD/TID in 2006 was lower than that recorded in Scandinavian countries. The use of these drugs increased in Finland by 9.9% and in Denmark by 10.1%. In Zagreb, a reduction of their consumption was recorded in 2006 relative to 2001 (19%). The utilization of psycholeptics (N05) was by 22% higher than in Denmark ; in 2001 it was the same as in Finland whereas in 2006 it was by 28% lower than in Finland. In Zagreb, the utilization of psycholeptics (N06), 90% of them antidepressants, was 2.3 times lower than the lowest rate in Finland , and 4 times lower than the highest rate in Denmark. Anxiolytics accounted for 90% of psycholeptic utilization in Zagreb versus 29% in Denmark and 34% in Finland. The anxiolytic/antidepressant ratio decreased in Croatia by 35.19% (7.19 in 2001 and 3.83 in 2006), whereas in Scandinavian countries it showed a constant rate (0.7 in Finland and 0.4 in Denmark). Conclusion: In Zagreb, benzodiazepines as a symptomatic rather than etiologic therapy accounted for 86.9% of psychopharmaceutical utilization, pointing to the need of respective guidelines as a measure of rationalization.

Izvorni jezik
Engleski

Znanstvena područja
Javno zdravstvo i zdravstvena zaštita

POVEZANOST RADA